A
8.25
0.24 (3.00%)
| Penutupan Terdahulu | 8.01 |
| Jumlah Dagangan | 5,475 |
| Harga / Pendapatan (P/E Ke hadapan) | 15.15 |
| Harga / Jualan (P/S) | 18.42 |
| Julat 52 Minggu |
| Margin Keuntungan | -7.83% |
| Margin Operasi (TTM) | 49.53% |
| EPS Cair (TTM) | -2.26 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 258.80% |
| Nisbah Semasa (MRQ) | 0.570 |
| Aliran Tunai Operasi (OCF TTM) | -67.24 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -62.49 M |
| Pulangan Atas Aset (ROA TTM) | -1.77% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Atara Biotherapeutics, Inc. | Bercampur | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -1.5 |
| Purata Bergerak Teknikal | -1.5 |
| Osilator Teknikal | -2.5 |
| Penilaian Relatif | NA |
| Kesihatan Kewangan | -5.0 |
| Persekitaran Makro | -2.8 |
| AI Insight | NA |
| AI Technical | NA |
| Purata | -1.96 |
|
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 22.44% |
| % Dimiliki oleh Institusi | 51.06% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Staley Capital Advisers Inc | 30 Jun 2026 | 50,000 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |